V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20195212 | 20124822 | 1.87 | 82 | null | 2021-05-28 | 2021-06-01 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 100228676 |
| 20195216 | 20124823 | 1.69 | 74 | Neo-adjuvant (N) | 2017-02-13 | 2017-02-15 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100349247 |
| 20195218 | 20124824 | 1.61 | 104 | Palliative (P) | null | 2017-10-17 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101527735 |
| 20195220 | 20124825 | 1.65 | 79 | null | 2019-11-27 | 2019-12-18 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101614687 |
| 20195222 | 20124826 | 1.72 | 74 | null | 2017-07-04 | 2017-08-12 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100971498 |
| 20195224 | 20124827 | 1.84 | null | Palliative (P) | 2016-08-30 | 2016-09-05 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101054763 |
| 20195225 | 20124828 | 1.66 | 64.9 | Neo-adjuvant (N) | 2019-05-09 | 2019-05-26 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101226081 |
| 20195227 | 20124829 | 1.88 | 112 | Neo-adjuvant (N) | 2018-10-15 | 2018-10-19 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101469734 |
| 20195229 | 20124830 | 1.76 | 63.75 | null | 2019-08-25 | 2019-09-08 | Docetaxel | 02 | null | DOCETAXEL | 101610782 |
| 20195238 | 20124831 | null | 143.7 | Palliative (P) | 2020-02-14 | 2020-02-18 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100877368 |
| 20195241 | 20124832 | 1.79 | 74.4 | Palliative (P) | 2019-08-06 | 2019-08-06 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100824760 |
| 20195247 | 20124833 | 1.91 | 46 | Palliative (P) | 2017-08-01 | 2017-08-17 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101053553 |
| 20195253 | 20124834 | 1.95 | 55 | Palliative (P) | 2018-10-23 | 2018-11-09 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100199770 |
| 20195254 | 20124835 | 1.63 | 74.6 | Palliative (P) | 2019-04-27 | 2019-10-19 | Cetuximab + FOLFIRI cycle1 | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100598219 |
| 20195255 | 20124836 | 1.61 | 63 | Palliative (P) | 2016-06-26 | 2016-06-27 | Docetaxel | 02 | N | DOCETAXEL | 100951028 |
| 20195257 | 20124837 | 1.51 | 55.9 | Palliative (P) | 2016-06-02 | 2016-11-17 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100564342 |
| 20195258 | 20124838 | 0 | 103 | null | 2019-07-19 | 2019-08-18 | Cetuximab + FOLFIRI cycle1 | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100478430 |
| 20195260 | 20124839 | 1.68 | 49 | null | 2020-10-15 | 2020-10-18 | Docetaxel 75mg/m2 (21 day) | null | null | DOCETAXEL | 100598579 |
| 20195265 | 20124840 | 1.86 | 68.3 | Curative (C) | 2019-12-27 | 2020-01-28 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100510173 |
| 20195268 | 20124841 | null | 70.7 | null | 2017-02-16 | 2017-03-04 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 101326457 |
| 20195276 | 20124842 | 1.75 | 69.3 | 03 | 2018-06-13 | 2018-07-03 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100270188 |
| 20195290 | 20124843 | 1.81 | 71 | null | 2017-07-01 | 2017-07-01 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | DOCETAXEL | 100931447 |
| 20195292 | 20124844 | 1.66 | 54.8 | Palliative (P) | 2017-12-14 | 2018-03-12 | Docetaxel 75mg/m2 (21 day) | N | N | DOCETAXEL | 100235796 |
| 20195293 | 20124845 | 1.76 | 73.2 | Adjuvant (A) | 2016-12-21 | 2016-12-21 | Docetaxel | 02 | N | DOCETAXEL | 100961992 |
| 20195294 | 20124846 | 1.79 | 54 | Palliative (P) | 2018-03-21 | 2018-03-25 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101027355 |
| 20195297 | 20124847 | 1.69 | 69.6 | null | 2016-05-23 | 2016-05-23 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100461853 |
| 20195298 | 20124848 | 1.76 | 102.4 | Palliative (P) | 2019-10-31 | 2019-11-08 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 101565116 |
| 20195300 | 20124849 | null | 64.8 | Palliative (P) | 2018-12-19 | 2018-12-22 | Gemcitabine + Capecitabine | null | N | CAPECITABINE + GEMCITABINE | 101636282 |
| 20195304 | 20124850 | 1.67 | 67 | Palliative (P) | 2018-11-24 | 2018-12-14 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100943425 |
| 20195308 | 20124851 | 1.7 | 69.7 | Adjuvant (A) | 2018-12-25 | 2018-12-29 | CAPECITABINE + GEMCITABINE | 99 | N | CAPECITABINE + GEMCITABINE | 100752980 |
| 20195314 | 20124852 | null | 82 | Palliative (P) | 2019-05-21 | 2019-05-25 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | DOCETAXEL | 100339827 |
| 20195315 | 20124853 | null | 85 | null | 2020-06-24 | 2020-06-26 | Docetaxel | 02 | null | DOCETAXEL | 101373116 |
| 20195316 | 20124854 | 1.77 | 60.3 | Palliative (P) | 2019-05-06 | 2019-05-16 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101125463 |
| 20195317 | 20124855 | 1.66 | 53.9 | Curative (C) | 2018-06-26 | 2018-11-14 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100890761 |
| 20195320 | 20124856 | 1.55 | 71.8 | Palliative (P) | 2018-11-29 | 2018-12-09 | Docetaxel | 02 | N | DOCETAXEL | 100668287 |
| 20195322 | 20124857 | 1.66 | 91 | Adjuvant (A) | 2019-09-14 | 2019-09-28 | Cetuximab + FLUOROURACIL + IRINOTECAN | 01 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101037744 |
| 20195325 | 20124858 | 1.84 | 74 | Palliative (P) | 2022-01-18 | 2022-01-18 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100533701 |
| 20195326 | 20124859 | 1.8 | 95.6 | null | 2017-09-22 | 2017-12-23 | Docetaxel | N | null | DOCETAXEL | 101251662 |
| 20195327 | 20124860 | 1.69 | 87 | Adjuvant (A) | null | 2017-01-11 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CAPECITABINE + GEMCITABINE | 101567909 |
| 20195329 | 20124861 | 1.6 | 57 | Palliative (P) | 2017-12-14 | 2018-02-09 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100665206 |
| 20195335 | 20124862 | 1.65 | 55 | Palliative (P) | 2017-04-12 | 2017-04-22 | Docetaxel | 02 | N | DOCETAXEL | 100762920 |
| 20195336 | 20124863 | 1.73 | 80.5 | Palliative (P) | 2017-05-13 | 2017-05-15 | Trastuzumab 21 day loading dose | N | N | TRASTUZUMAB | 100740392 |
| 20195339 | 20124864 | 1.88 | 87.55 | null | 2019-01-11 | 2019-01-15 | TRASTUZUMAB | 02 | null | CETUXIMAB | 100562007 |
| 20195340 | 20124865 | 1.72 | 80.6 | Curative (C) | 2018-12-14 | 2019-02-13 | Trastuzumab | null | N | TRASTUZUMAB | 101184271 |
| 20195342 | 20124866 | 1.74 | 61.6 | Palliative (P) | null | 2017-06-20 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 100866510 |
| 20195351 | 20124867 | 1.64 | 100.7 | null | 2017-08-20 | 2017-08-29 | CETUXIMAB | 02 | Y | CETUXIMAB | 101092509 |
| 20195352 | 20124868 | 1.72 | 106 | Palliative (P) | 2019-09-21 | 2019-10-11 | CETUXIMAB | N | N | TRASTUZUMAB | 101016564 |
| 20195354 | 20124869 | 1.64 | 56.45 | Curative (C) | 2018-03-10 | 2018-05-23 | Capecitabine + Cisplatin | 02 | null | CETUXIMAB | 100634107 |
| 20195358 | 20124870 | 1.7 | 71.3 | null | 2018-08-23 | 2018-08-23 | Trastuzumab 21 day maintenance | 02 | null | TRASTUZUMAB | 101836466 |
| 20195368 | 20124871 | 1.58 | 115.2 | Palliative (P) | null | 2017-05-11 | Trastuzumab 21 day maintenance | 02 | N | TRASTUZUMAB | 100758774 |